Death‐associated protein kinase 1 suppresses hepatocellular carcinoma cell migration and invasion by upregulation of DEAD‐box helicase 20. Issue 8 (26th June 2020)

• Record Type: Journal Article
• Authors: Huang, Yide; Wang, Chenyi; Li, Ke; Ye, Yan; Shen, Aling; Guo, Libin; Chen, Pengchen; Meng, Chen; Wang, Qingshui; Yang, Xinliu; Huang, Zhen; Xing, Xiaohua; Lin, Youyu; Liu, Xiaolong; Peng, Jun; Lin, Yao
• Is Part Of: Cancer science. Volume 111:Issue 8(2020)
• Page Start: 2803
• Page End: 2813
• Publication Date: 2020-06-26
• Subjects: DEAD‐box helicase 20 -- death‐associated protein kinase -- hepatocellular carcinoma -- invasion -- migration -- proteasome degradation; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.14499
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract: Death‐associated protein kinase 1 (DAPK) is a calcium/calmodulin kinase that plays a vital role as a suppressor gene in various cancers. Yet its role and target gene independent of p53 is still unknown in hepatocellular carcinoma (HCC). In this study, we discovered that DAPK suppressed HCC cell migration and invasion instead of proliferation or colony formation. Using a proteomics approach, we identified DEAD‐box helicase 20 (DDX20) as an important downstream target of DAPK in HCC cells and critical for DAPK‐mediated inhibition of HCC cell migration and invasion. Using integrin inhibitor RGD and GTPase activity assays, we discovered that DDX20 suppressed HCC cell migration and invasion through the CDC42‐integrin pathway, which was previously reported as an important downstream pathway of DAPK in cancer. Further research using cycloheximide found that DAPK attenuates the proteasomal degradation of DDX20 protein, which is dependent on the kinase activity of DAPK. Our results shed light on new functions and regulation for both DAPK and DDX20 in carcinogenesis and identifies new potential therapeutic targets for HCC. Abstract : This work identifies DEAD‐box helicase 20 (DDX20) as a new downstream target of death‐associated protein kinase 1 (DAPK). DAPK suppresses hepatocellular carcinoma cell migration and invasion, but not proliferation or colony formation, through DDX20.